473 related articles for article (PubMed ID: 25230823)
1. Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin.
Govender J; Loos B; Marais E; Engelbrecht AM
J Pineal Res; 2014 Nov; 57(4):367-80. PubMed ID: 25230823
[TBL] [Abstract][Full Text] [Related]
2. Melatonin: a protective role against doxorubicin-induced cardiotoxicity.
Govender J; Loos B; Engelbrecht AM
Future Oncol; 2015; 11(14):2003-6. PubMed ID: 26198826
[No Abstract] [Full Text] [Related]
3. Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity?
Govender J; Loos B; Marais E; Engelbrecht AM
Toxicol Appl Pharmacol; 2018 Nov; 358():86-101. PubMed ID: 29966675
[TBL] [Abstract][Full Text] [Related]
4. The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review.
Najafi M; Hooshangi Shayesteh MR; Mortezaee K; Farhood B; Haghi-Aminjan H
Life Sci; 2020 Jan; 241():117173. PubMed ID: 31843530
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics.
Arinno A; Maneechote C; Khuanjing T; Ongnok B; Prathumsap N; Chunchai T; Arunsak B; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Biochem Pharmacol; 2021 Oct; 192():114743. PubMed ID: 34453902
[TBL] [Abstract][Full Text] [Related]
6. Melatonin prevents doxorubicin-induced cardiotoxicity through suppression of AMPKα2-dependent mitochondrial damage.
Yang G; Song M; Hoang DH; Tran QH; Choe W; Kang I; Kim SS; Ha J
Exp Mol Med; 2020 Dec; 52(12):2055-2068. PubMed ID: 33339952
[TBL] [Abstract][Full Text] [Related]
7. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.
Koleini N; Kardami E
Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146
[TBL] [Abstract][Full Text] [Related]
8. The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review.
Razavi-Azarkhiavi K; Iranshahy M; Sahebkar A; Shirani K; Karimi G
Nutr Cancer; 2016; 68(6):892-917. PubMed ID: 27341037
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of melatonin on adriamycin-induced cardiotoxicity in rats.
Bilginoğlu A; Aydın D; Ozsoy S; Aygün H
Turk Kardiyol Dern Ars; 2014 Apr; 42(3):265-73. PubMed ID: 24769819
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effect of melatonin and agomelatine on doxorubicin-induced cardiotoxicity in a rat model: an electrocardiographic, scintigraphic and biochemical study.
Aygun H; Gul SS
Bratisl Lek Listy; 2019; 120(4):249-255. PubMed ID: 31023046
[TBL] [Abstract][Full Text] [Related]
11. Melatonin protection against lethal myocyte injury induced by doxorubicin as reflected by effects on mitochondrial membrane potential.
Xu M; Ashraf M
J Mol Cell Cardiol; 2002 Jan; 34(1):75-9. PubMed ID: 11812166
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.
He L; Liu F; Li J
Cardiovasc Toxicol; 2021 Mar; 21(3):179-191. PubMed ID: 33438065
[TBL] [Abstract][Full Text] [Related]
13. Prevention of doxorubicin-induced cardiotoxicity by melatonin.
Oz E; Erbaş D; Sürücü HS; Düzgün E
Mol Cell Biochem; 2006 Jan; 282(1-2):31-7. PubMed ID: 16317509
[TBL] [Abstract][Full Text] [Related]
14. Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts.
Huang L; Zhang K; Guo Y; Huang F; Yang K; Chen L; Huang K; Zhang F; Long Q; Yang Q
Sci Rep; 2017 Sep; 7(1):11989. PubMed ID: 28931882
[TBL] [Abstract][Full Text] [Related]
15. Role of mitochondria in doxorubicin-mediated cardiotoxicity: From molecular mechanisms to therapeutic strategies.
Wang T; Xing G; Fu T; Ma Y; Wang Q; Zhang S; Chang X; Tong Y
Cell Stress Chaperones; 2024 Apr; 29(2):349-357. PubMed ID: 38485043
[TBL] [Abstract][Full Text] [Related]
16. A review of the protective role of melatonin during phosphine-induced cardiotoxicity: focus on mitochondrial dysfunction, oxidative stress and apoptosis.
Asghari MH; Abdollahi M; de Oliveira MR; Nabavi SM
J Pharm Pharmacol; 2017 Mar; 69(3):236-243. PubMed ID: 28000313
[TBL] [Abstract][Full Text] [Related]
17. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.
Henninger C; Huelsenbeck S; Wenzel P; Brand M; Huelsenbeck J; Schad A; Fritz G
Pharmacol Res; 2015 Jan; 91():47-56. PubMed ID: 25462173
[TBL] [Abstract][Full Text] [Related]
18. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
Conklin KA
Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925
[TBL] [Abstract][Full Text] [Related]
19. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.
Asensio-Lopez MC; Sanchez-Mas J; Pascual-Figal DA; de Torre C; Valdes M; Lax A
Free Radic Biol Med; 2014 Feb; 67():19-29. PubMed ID: 24231192
[TBL] [Abstract][Full Text] [Related]
20. Sesamin ameliorates doxorubicin-induced cardiotoxicity: involvement of Sirt1 and Mn-SOD pathway.
Su S; Li Q; Liu Y; Xiong C; Li J; Zhang R; Niu Y; Zhao L; Wang Y; Guo H
Toxicol Lett; 2014 Jan; 224(2):257-63. PubMed ID: 24211423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
